149 related articles for article (PubMed ID: 27198457)
1. Another Piece of the Puzzle of Podocyte B7-1 Expression: Lupus Nephritis.
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Nephron; 2016; 133(2):129-38. PubMed ID: 27198457
[TBL] [Abstract][Full Text] [Related]
2. DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis.
Cai M; Zhou T; Wang X; Shang M; Zhang Y; Luo M; Xu C; Yuan W
Clin Exp Immunol; 2016 Mar; 183(3):317-25. PubMed ID: 26440060
[TBL] [Abstract][Full Text] [Related]
3. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
5. The immune podocyte.
Bhargava R; Tsokos GC
Curr Opin Rheumatol; 2019 Mar; 31(2):167-174. PubMed ID: 30562182
[TBL] [Abstract][Full Text] [Related]
6. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
Jin J; Ye M; Zhao L; Zou W; Shen W; Zhang H; Gong J; He Q
Histol Histopathol; 2018 Aug; 33(8):803-814. PubMed ID: 29446059
[TBL] [Abstract][Full Text] [Related]
7. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
8. Immune podocytes in the immune microenvironment of lupus nephritis (Review).
Liu R; Wen X; Peng X; Zhao M; Mi L; Lei J; Xu K
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711069
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
Zhang Z; Niu L; Tang X; Feng R; Yao G; Chen W; Li W; Feng X; Chen H; Sun L
Nephrol Dial Transplant; 2019 Apr; 34(4):597-605. PubMed ID: 29982691
[TBL] [Abstract][Full Text] [Related]
10. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
Ichinose K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Arima K; Nakamura H; Obata Y; Yamamoto K; Origuchi T; Nishino T; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Apr; 68(4):944-52. PubMed ID: 26636664
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches.
Dos Santos M; Poletti PT; Milhoransa P; Monticielo OA; Veronese FV
Semin Arthritis Rheum; 2017 Apr; 46(5):632-641. PubMed ID: 27839739
[TBL] [Abstract][Full Text] [Related]
12. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
[TBL] [Abstract][Full Text] [Related]
13. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
14.
Chen W; Wu Y; Zhang G; Wang M; Yang H; Li Q
Biomed Res Int; 2018; 2018():5647120. PubMed ID: 29862277
[TBL] [Abstract][Full Text] [Related]
15. The costimulatory receptor B7-1 is not induced in injured podocytes.
Baye E; Gallazzini M; Delville M; Legendre C; Terzi F; Canaud G
Kidney Int; 2016 Nov; 90(5):1037-1044. PubMed ID: 27528551
[TBL] [Abstract][Full Text] [Related]
16. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
[TBL] [Abstract][Full Text] [Related]
17. Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses.
Qian B; Lu R; Mao S; Chen Y; Yang M; Zhang W; Zhang M; Zhu D; Liu Z; Zen K; Li L
Cell Rep; 2024 May; 43(5):114249. PubMed ID: 38758648
[TBL] [Abstract][Full Text] [Related]
18. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
Yuan M; Tan Y; Wang Y; Wang SX; Yu F; Zhao MH
Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145
[TBL] [Abstract][Full Text] [Related]
19. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.
Xu C; Miao Y; Pi Q; Zhu S; Li F
Clin Immunol; 2018 Dec; 197():179-185. PubMed ID: 30296590
[TBL] [Abstract][Full Text] [Related]
20. Podocytes and autophagy: a potential therapeutic target in lupus nephritis.
Zhou XJ; Klionsky DJ; Zhang H
Autophagy; 2019 May; 15(5):908-912. PubMed ID: 30755075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]